chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I felt extremely tired a few hours after vaccine, however I knew that was a normal side effect so it didn't bother me. The next day I had extreme fog, a daily/normal task took a lot more effort. I kept telling my husband I feel "off." I went to the grocery store in which I suddenly got a hot flash and dizziness and had to sit down immediately before I was about to pass out. That was on November 18th. Then I was feeling semi normal again until December 1st, exactly two weeks after my booster. I had another episode in which I felt like I was going to pass out, my heart rate spiked, I felt dizzy, tingling in feet and hands, and had to lay down to get it under control. This continued to happen each day from December 1st-December 4th. I haven't had a 'almost passing out' episode again but I do have to be very intentional with breathing and I have to sit a lot of the day from fatigue. I'm a very active, healthy 39 year old that works out typically 4-5 days a week, so this sudden urge to have to stop and catch my breathing isn't normal.
The day after vaccination the patient's mother noticed a red spot developing. The next day she brought her daughter in to be seen and noted it was worse. When I saw her two days after the injection I noted: macular target appearing lesion to right bicep erythematous appx 2 inches with surrounding pink tones to skin appx 4 inches in diameter. Appeared as though pt did not feel pain or itching associated but it was warm to the touch as well.
Patient started to feel panicked and dizzy approximately 5 minutes after receiving the vaccine. About 2 minutes later he vomited, and then vomited again about 10 minutes later. He was conscious the entire time and could see me and speak to me coherently. She was sweating profusely. We provided an ice pack and called 911. EMS arrived and took his vitals, which  they said were perfectly normal. The patient refused to go to the hospital and hung around the pharmacy for another 10 minutes before leaving, saying he felt much better.
This spontaneous report as received from a medical assistant refers to a 12 month old male patient. On 22-JUN-2018, the patient was vaccinated with improperly stored dose of VAQTA lot # N023953, expiration date 05-NOV-2018 for prophylaxis. The vaccine underwent a temperature excursion of 9 to 25 degrees Celsius for 20 minutes. No previous temperature excursions were reported. Digital data logger was invloved. No adverse events were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1806USA010964: US-009507513-1807USA006807: US-009507513-1807USA006808: US-009507513-1807USA006810:
This spontaneous case was reported by a consumer and describes the occurrence of BLINDNESS (He could no longer see/ He was blind) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A, 022M20A and 030L20A) for COVID-19 vaccination. Concomitant products included CARBIDOPA, LEVODOPA (CARBIDOPA LEVODOPA) and PROBENECID for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Sep-2021 at 11:45 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Sep-2021 at 12:45 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BLINDNESS (He could no longer see/ He was blind) (seriousness criterion medically significant). At the time of the report, BLINDNESS (He could no longer see/ He was blind) outcome was unknown. The patient was blind and he could no longer see after booster dose vaccination. No treatment information was provided. Company Comment: This case concerns a 87-year-old male patient with no reported medical history, under concomitant medications carbidopa-levodopa and probenecid, who experienced the serious unexpected event Blindness. The event occurred more than 6 months after the second dose and 1 hour after the third and most recent dose of mRNA-1273 Moderna vaccine. No information is available regarding medical history that could be confounders for the events.  Further information has been requested. The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report. This case was linked to MOD-2021-327765 (Patient Link).; Sender's Comments: This case concerns a 87-year-old male patient with no reported medical history, under concomitant medications carbidopa-levodopa and probenecid, who experienced the serious  unexpected event Blindness. The event occurred more than 6 months after the second dose and 1 hour  after the third and most recent dose of mRNA-1273 Moderna vaccine. No information is available regarding medical history that could be confounders for the events. Further information has been requested. The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.
This is spontaneous report was received from a physician via two company representatives and from a practice manager (support services director) and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 08-OCT-2014, the patient was vaccinated with an improperly stored dose of GARDASIL injection, lot # K005083, expiration date 04-NOV-2016 (dose, route and site of administration were not reported). The administered dose of vaccine was exposed to temperature excursion (date unspecified): lasting for 72 hours, with the lowest recorded temperature of 28 degree Fahrenheit (-2.222222222 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical histories, drug reactions or allergies and concomitant therapies was provided. On unknown dates from 25-APR-2017 to 24-MAY-2017, the patients were vaccinated with improperly stored doses of VAQTA lot # M038572, expiration date 11-MAR-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 47 degrees Fahrenheit to 77 degrees Fahrenheit for 30 minutes. Data logger was involved. There were no previous excursions reported. No product quality complaint was involved. Additional information has been requested.
When I got up Monday morning, I noticed I had a enlarge lymph node, in the same arm where the vaccine was given.  It was the size of a tennis ball. I went to the Doctor, she did a chest xray and blood work to rule out lymphoma. That came back negative and I have had some shortness of breath.  This hasn't went away, has got smaller but still there, My PCP is keeping an eye on it.
Covid arm rash at injection site appeared a week after injection.  Rash was warm and mildly itchy.  Rash has cleverly persisted for 4 days (and is still present).
Pain near injection sight, muscular and joint paint throughout body especially on left side of body, headaches, fatigue
Dizziness; Headache; Low grade fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEADACHE (headache), PYREXIA (low grade fever) and NAUSEA (nausea) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (6 months ago).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), HEADACHE (headache), PYREXIA (low grade fever) and NAUSEA (nausea). At the time of the report, DIZZINESS (dizziness), HEADACHE (headache), PYREXIA (low grade fever) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
My COVID-19 symptoms started on 03/07/2023 in the morning I had fever, nasal congestions, cough, and body aches. Since I was on vacation I went to the pharmacy to get tested. My test results came in on 03/09/2023 which was positive. I went to a local clinic on the same day. They prescribed me PAXLOVID for 5 days.
About 6pm began feeling achy and running a fever.  Continued through the next day with fever reaching 101.7 (mine normally is 97.8), with chills and moderate achiness, extreme pain in left arm where pneumonia vaccination received.  By 7:30 am Wednesday morning was experiencing nausea.  Called doctor and was seen at 8:30 am.  No sign of flu or pneumonia present.  Sent home with antibiotic Levaquin as a precautionary measure.  Took Levaquin at 10:00am.  By noon fever had reduced to 100.  Took second dose of Levaquin around 8 am Thursday morning. Redness that had been all over body, localized to injection site about the size of a golf ball.  Upper arm swollen about an inch.  By 9 pm the injection site was the size of a tennis ball, bright red with red fingers spreading out from in in three directions.  Called doctor at 9:00 was given Bactrim.  Counseled to visit office again in morning during office hours.  Friday morning saw doctor at 9:20.  Confirmed that there was a strep infection in my arm at the site of the pneumonia vaccination.
Pt c/o swollen arm, fever, redness at injection site. Pt took Tylenol and Vicoden. Pt states that she is doing better.
Vaccines given at approx 1:30, left clinic without incident. Returned to clinic approx 30 mins later. Pt's cheeks red with 4-5 hives, no redness or hives noted elsewhere. No respiratory or other distress. Given Benadryl at urgent care. Hives went away approx 15 mins after Benadryl.
"Hot, flushing, took Benadryl liquid po several doses, i had chest tightness and could not take a full breath until the next morning"
Bowel blockage started Saturday  6/12/21  during breakfast. Had stabbling pains in lower abdomen and violent vomiting, especially water.  Lost 10 pounds.  Went to ER late afternoon 6/13/21. Admitted morning of 6/14/21,  discharged Saturday 6/19/21. Had NG tube. Received antibiotics and potassium by IV. Had atrial fibrillation and  AKI (acute kidney injury from depletion of electrolytes).
Slight headache; chills; soreness at injection site; lightheadedness; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 30Mar2021 at 08:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, neuropathy, and pre-diabetes. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atorvastatin calcium (LIPITOR), herbal pollen (RELIZEN), and unspecified multivitamins. The patient previously took cefazolin sodium (KEFZOL) and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced slight headache, chills, soreness at injection site, and lightheadedness on 30Mar2021 at 09:00. The patient did not receive any treatment as a result of the events. The clinical outcome of slight headache, chills, soreness at injection site, and lightheadedness was recovering.  No follow-up attempts are possible. No further information is expected.
Swollen lump that is quite sore on her left arm; Swollen lump that is quite sore on her left arm; This is a spontaneous report from a contactable Nurse (patient). A 84-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231, Expiry Date: Apr2021) via an unspecified route of administration in Jan2021 at single dose for vaccination. Dose injection to left deltoid around 14:00. Medical history included car wreck, hypertension, scoliosis. Concomitant medication included ongoing celecoxib (CELEBREX) for car wreck, amlodipine besilate, benazepril hydrochloride (AMLODIPINE/BENAZEPRIL) from 2017 and ongoing for anti-hypertension. The patient reported she had the Pfizer COVID-19 Vaccine a week ago and it did not really bother her until she started trying to do exercises of her arm. On 15Jan2021 she had a swollen lump that is quite sore on her left arm that did not go down and it had been 3 days now. She did not have a fever, the area was not red, it's just swollen. She just wanted to know if this event was customary with the product; and if her second dose should be given in a different anatomical location. It was just painful and swollen; had not been hospitalized for this event. She could see the difference, she was quite wrinkled now with age; but at the site of her swollen lump on left arm she had no wrinkles right now. Her second dose is scheduled for 02Feb2021 at 14:20. The outcome of events was not recovered.
Patient arrived at pharmacy 9/29/23 2:12 PM, one day after her immunization. Her left arm had swelling around the injection site around a foot circumference. Patient stated that it felt hot, swollen, and itchy. There was a hard line around the reaction area. No spread towards torso or neck. No complaints of breathing.
Patient began experiencing some shortness of breath 15 minutes after the injection with audible wheezing.  This nurse assessed her and found the following: LS tight/rhonci  whole L side w/wheezing in bilat upper lungs, O2 sat 96% on RA, skin pink/warm, no change in color, no diaphoresis noted, HR regular/98. Patient was able to converse. 911 was activated, paramedics heard air movement throughout lungs, still 96% on RA, BP 141/92. Taken by ambulance to ED due to long history of asthma and no recue inhaler on her person.
This spontaneous report as received from a consumer refers to a 79 year old female patient (reporter's wife). The patient's medical history included trabeculectomia. It was reported that on an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and lot number not reported). Additionally it was reported that on an unknown date the patient experienced the rash (unspecified). The outcome of rash (unspecified) was not reported. The relatedness between the rash and the vaccination with ZOSTAVAX was not reported. This case is linked with MARRS #1307USA009864 (Same Patient Link)
Within the first 24 hours after the vaccine patient experienced: blackout 1.5 hours after the vaccine  headache loss of vision, hearing, and sensations, nausea chest pain productive cough of different color sputum. Currently patient is experiencing productive cough and headache
Patient responded well to vaccine and stated it that it did not hurt at all. Patient put her sweatshirt on and jacket on and stood up and was talking with mother and RN without problems. Mother and Rn were talking and patient fell into cabinet in nurses office. Rn immediately assessed patient who had her eyes open with a look of fear and carried her to exam table. Patient did not remember falling. Rn questioned patient on how she was feeling. Patient stated that she felt sick. Rn had her lay down on exam table for approx 10 minutes and then was provided some crackers and water. Patient stayed in nurses office for approx 20 min total until she was feeling better. Rn did assess child's head r/t fall. Patient had hit her left ear on cabinet with slight redness noted to ear. No further injury and patient denied any pain. Rn contacted mother the next day and left voicemail to check on patient with no response. Rn contacted mother again the following day and spoke with her. Mother states that child is fine and that she "rode" it out for a little bit  that evening but has had no further complications. Rn advised mother in the future to tell healthcare personnel that the child has history of passing out post vaccinations.
Per pt, he developed bruises on the injection site as well as on chest areas. He had to go to ER. FYI: (Pt is on 81 mg aspirin).
Injections site redness, rash on injection arm, stomach and legs.  Low-grade fever (max 100.3), nausea/vomiting, headache
painful rash near her knees; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "painful rash near her knees". Additional information: Patient just got her dose of the Pfizer Covid 19 vaccine Bivalent (referred to as the new booster, clarified as the Omicron one) this morning, she reported that right now she was experiencing a painful rash near her knees just above her knee on the inside of her leg. She described that it was only painful when something rubs against it and that anyone can hardly see it. She was asking if this has been a previously reported side effect with the Bivalent vaccine. She asked if this rash has anything to say it about what could happen next to her. She also asked how long it will last.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
1 day Fever 101.4. Body aches, lethargy, headache. 5 day Diarrhea. Treatments Ibuprofen for fever and nothing for intestinal discomfort.
Patient received a fifth dose of anthrax vaccine on 3/17/2004.  He was well prior to vaccination and did not recall immediate local or systemic symptoms.  On 4/14/2004 he presented to a military treatment facility with a 3-day history of chest pain and SOB.  He was diagnosed and treated for acute pericarditis based on clinical presentation and elevated ESR; no ECG was obtained.  Chest pain, sub-sternal start: 03/11/2004.  Dyspnea (shortness of breath) start: 03/11/2004.
extremely severe arm pain, 6 or 7/10, aching quality, located at shot site and radiating down towards hand and up to shoulder, regular arm movements and ibuprofen did not help, could not use shot arm for 3 days. almost went to ER because it was so severe but I knew they wouldn't be able to do anything about it. after 72 hours began to get noticeably better but was sore for probably 3 more days
swelling at injection site (Affected area was spreading around the arm and down); Rednessat the injection site (Affected area was spreading around the arm and down); Itchy/extremely itchy at injection site (Affected area was spreading around the arm and down); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy/extremely itchy at injection site (Affected area was spreading around the arm and down)), VACCINATION SITE SWELLING (swelling at injection site (Affected area was spreading around the arm and down)) and VACCINATION SITE ERYTHEMA (Rednessat the injection site (Affected area was spreading around the arm and down)) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0025H21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy/extremely itchy at injection site (Affected area was spreading around the arm and down)). On 14-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling at injection site (Affected area was spreading around the arm and down)) and VACCINATION SITE ERYTHEMA (Rednessat the injection site (Affected area was spreading around the arm and down)). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchy/extremely itchy at injection site (Affected area was spreading around the arm and down)), VACCINATION SITE SWELLING (swelling at injection site (Affected area was spreading around the arm and down)) and VACCINATION SITE ERYTHEMA (Rednessat the injection site (Affected area was spreading around the arm and down)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Certaline 50 mg Treatment included "Icing"
Bronchitis; Asthmatic attack; Swelling in legs; pain in legs; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis), ASTHMA (Asthmatic attack), PERIPHERAL SWELLING (Swelling in legs) and PAIN IN EXTREMITY (pain in legs) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ulcerative colitis and Crohn's disease.    Concurrent medical conditions included Ulcerative colitis (moderate to severe) and Crohn's disease (moderate to severe adult crohn's disease).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced BRONCHITIS (Bronchitis), ASTHMA (Asthmatic attack), PERIPHERAL SWELLING (Swelling in legs) and PAIN IN EXTREMITY (pain in legs). At the time of the report, BRONCHITIS (Bronchitis), ASTHMA (Asthmatic attack) and PERIPHERAL SWELLING (Swelling in legs) was resolving and PAIN IN EXTREMITY (pain in legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's Causality for Humira(adalimumab) for the event(s) of bronchitis, asthma attack, swelling in legs and pain in legs was not provided.  No treatment details were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact
While injecting vaccine, syringe malfunctioned when spring action to retract the needle broke and cause a partial dose to enter patient and the rest leaked out of syringe.  It is unknown how much vaccine patient received.
5-10 minutes after injection, my mouth had a lot of excess saliva, and I got a severe and sudden metallic taste in my mouth.  And my  tongue feels somewhat numb and like it is coated.
Chills which lasted for only about three hours the evening after receiving the shot, started approximately 3 hours after the dose and lasted for only a few hours.